In vitro–in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink model

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéuticagl
dc.contributor.authorMota, Ana F. Pereira da
dc.contributor.authorVivero López, María
dc.contributor.authorGarg, Piyush
dc.contributor.authorPhan, Chau-Minh
dc.contributor.authorConcheiro Nine, Ángel Joaquín
dc.contributor.authorJones, Lyndon
dc.contributor.authorÁlvarez Lorenzo, Carmen
dc.date.accessioned2023-01-20T11:58:26Z
dc.date.available2023-01-20T11:58:26Z
dc.date.issued2022
dc.description.abstractThere is still a paucity of information on how in vitro release profiles from drug-loaded contact lenses (CLs) recorded in 3D printed eye models correlate with in vivo profiles. This work aims to evaluate the release profiles of two drug-loaded CLs in a 3D in vitro eye blink model and compare the obtained results with the release in a vial and the drug levels in tear fluid previously obtained from an animal in vivo study. In vitro release in the eye model was tested at two different flow rates (5 and 10 µL/min) and a blink speed of 1 blink/10 s. Model CLs were loaded with two different drugs, hydrophilic pravastatin and hydrophobic resveratrol. The release of both drugs was more sustained and lower in the 3D eye model compared to the in vitro release in vials. Interestingly, both drugs presented similar release patterns in the eye model and in vivo, although the total amount of drugs released in the eye model was significantly lower, especially for resveratrol. Strong correlations between percentages of pravastatin released in the eye model and in vivo were found. These findings suggest that the current 3D printed eye blink model could be a useful tool to measure the release of ophthalmic drugs from medicated CLs. Nevertheless, physiological parameters such as the composition of the tear fluid and eyeball surface, tear flow rates, and temperature should be optimized in further studiesgl
dc.description.peerreviewedSIgl
dc.description.sponsorshipOpen Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This project was funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Actions grant agreement N° 813440 (ORBITAL–Ocular Research by Integrated Training And Learning). The work was also partially supported by MCIN [PID 2020-113881RB-I00/AEI/10.13039/501100011033], Spain, Xunta de Galicia [ED431C 2020/17], FEDER, and the Hong Kong Special Administrative Region Government and InnoHK. M. Vivero-Lopez acknowledges Xunta de Galicia (Consellería de Cultura, Educación e Ordenación Universitaria) for a predoctoral research fellowship [ED481A-2019/120]. P. Garg acknowledges the support of the Collaborative Research and Training Experience (CREATE) Program awarded by the Natural Sciences and Engineering Research Council of Canada (NSERC)gl
dc.identifier.citationPereira-da-Mota, A.F., Vivero-Lopez, M., Garg, P. et al. In vitro–in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink model. Drug Deliv. and Transl. Res. (2022). https://doi.org/10.1007/s13346-022-01276-6gl
dc.identifier.doi10.1007/s13346-022-01276-6
dc.identifier.essn2190-3948
dc.identifier.issn2190-393X
dc.identifier.urihttp://hdl.handle.net/10347/29966
dc.language.isoenggl
dc.publisherSpringergl
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-113881RB-I00/ESgl
dc.relation.publisherversionhttps://doi.org/10.1007/s13346-022-01276-6gl
dc.rights© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/gl
dc.rightsAtribución 4.0 Internacional
dc.rights.accessRightsopen accessgl
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectDrug-eluting contact lensesgl
dc.subjectEye blink modelgl
dc.subjectIn vitro–in vivo correlationsgl
dc.subjectPravastatin sodiumgl
dc.subjectResveratrolgl
dc.titleIn vitro–in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink modelgl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublicationfbd9d3a4-b1f4-4aff-8472-de22b1c140c4
relation.isAuthorOfPublication44d6632e-65cd-485a-bb67-86df5567793a
relation.isAuthorOfPublication.latestForDiscoveryfbd9d3a4-b1f4-4aff-8472-de22b1c140c4

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022_drug_mota_invitro.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Description:
Artigo de investigación